(2S)-N-[(5S,8R)-1,12-diamino-8-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[2-[(2-amino-2-oxoethyl)amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]-6-oxododecan-5-yl]-1-[2-[[2-[4-[1-[4-[1-[6-(hydroxyamino)-6-oxohexyl]triazol-4-yl]phenyl]triazol-4-yl]butanoylamino]acetyl]amino]acetyl]pyrrolidine-2-carboxamide

InChIKey	`IUEFYRLPYAICCV-FCXUJXQASA-N`
Compound Name	(2S)-N-[(5S,8R)-1,12-diamino-8-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[2-[(2-amino-2-oxoethyl)amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]-6-oxododecan-5-yl]-1-[2-[[2-[4-[1-[4-[1-[6-(hydroxyamino)-6-oxohexyl]triazol-4-yl]phenyl]triazol-4-yl]butanoylamino]acetyl]amino]acetyl]pyrrolidine-2-carboxamide
Canonical SMILES	`CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)CC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)CNC(=O)CCCc1cn(-c2ccc(-c3cn(CCCCCC(=O)NO)nn3)cc2)nn1)C(=O)NCC(=O)NCC(N)=O`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	6.99
Source	ChEMBL;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q13547	HDAC1	Homo sapiens	Human	PF00850	7.4	pIC50	TTD_MultiTarget
Q92769	HDAC2	Homo sapiens	Human	PF00850	7.4	IC50	ChEMBL
Q02161	RHD	Homo sapiens	Human	PF00909	6.8	pIC50	TTD_MultiTarget
Q9UBN7	HDAC6	Homo sapiens	Human	PF00850 PF02148	6.2	IC50	ChEMBL